How to appeal a Premera Blue Cross adult adhd medications denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Premera Blue Cross-specific note: BCBS licensee for Washington and Alaska (~2.4M members). Express Scripts PBM. WA OIC oversight. WA has strong mental health parity enforcement and surprise-billing protections that pre-date federal NSA.

What Premera Blue Cross's policy requires for adult adhd medications

Cited policy: BCBS Prior Authorization Criteria — ADHD/Stimulant Medications (varies by plan; e.g., Anthem CG-MED-ADHD, Highmark Stimulants PA)

Wide variation. Most require DSM diagnosis, prior trial of >=1 generic stimulant for brand, dose within FDA label.

How Premera Blue Cross denies adult adhd medications — and how to counter it

Where Premera Blue Cross pushes back: 1) Adult new-start denials with 'ADHD typically diagnosed in childhood'; 2) Dose cap denials for Vyvanse >70mg or Adderall XR >30mg; 3) Concurrent benzodiazepine or opioid use flagged as contraindication.

Counter-arguments that hold up: World Federation of ADHD Consensus 2021 — adult-onset recognition is valid; late diagnosis common in women and high-IQ individuals who compensated. For doses above label: peer-reviewed dose-response (Wigal et al. on Vyvanse, Spencer et al. on amphetamine) — request medical exception with clinical justification. Stimulant + benzodiazepine NOT contraindicated; only requires monitoring per FDA label.

What Premera Blue Cross typically denies for adult adhd medications

Across Premera Blue Cross's commercial and Medicare books, denials cluster around a small number of patterns. For adult adhd medications, expect:

• WA-specific mental health parity violations
• Step therapy via Express Scripts
• Out-of-network reductions
• Specialty drug prior auth

Treatments most often denied in this category

These are the adult adhd medications treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Vyvanse
• Adderall XR
• Concerta
• Focalin XR
• Ritalin LA
• Strattera

How to submit the appeal to Premera Blue Cross

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Premera Blue Cross cited in the denial.
3. File the appeal through Premera Blue Cross's portal (members: https://www.premera.com ; providers: https://www.premera.com/wa/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In WA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Premera Blue Cross's prior-authorization criteria by drug: Premera Blue Cross PA criteria on ApprovalHelp.